TRVN - TREVENA INC
2.465
-2.560 -103.854%
Share volume: 0
Last Updated: Mon 07 Oct 2024 08:25:42 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-0.20%
PREVIOUS CLOSE
CHG
CHG%
$5.02
0.00
0.00%
View ratios
| Fiscal Date | 2024-09-30 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 2024-11-07 | |
| Assets | ||
| Total Assets | 19.188 M | |
| Current Assets | 14.735 M | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 13.462 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 923.000 K | |
| Other Assets | 3.530 M | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 19.188 M | |
| Total liabilities | 42.497 M | |
| Total current liabilities | 6.086 M | |
| Accounts Payable | 918.000 K | |
| Other liabilities | 4.439 M | |
| Current long term debt | 0.000 | |
| Long term debt | 31.972 M | |
| Other liabilities | 4.439 M | |
| Minority interest | 0.000 | |
| Total Shareholder equity | -23.309 M | |
| Common stock | 582.260 M | |
| Retained earnings | -605.569 M |